Hepatocyte growth factor activator inhibitor type 1 (HAI-1) is required for the integrity of intestinal epithelium

被引:0
|
作者
Kawaguchi, Makiko [1 ]
Fukushima, Tsuyoshi [1 ]
Takeda, Naoki [2 ]
Hoshiko, Shinri [1 ]
Yorita, Kenji [1 ]
Kohama, Kazuyo [1 ]
Orikawa, Hiroshi [1 ]
Baba, Takashi [1 ]
Kataoka, Hiroaki [1 ]
机构
[1] Miyazaki Univ, Miyazaki, Japan
[2] Kumamoto Univ, Kumamoto, Japan
来源
FASEB JOURNAL | 2010年 / 24卷
关键词
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Hepatocyte growth factor activator inhibitor type 1 (HAI-1) is required for branching morphogenesis in the chorioallantoic placenta
    Tanaka, H
    Nagaike, K
    Takeda, N
    Itoh, H
    Kohama, K
    Fukushima, T
    Miyata, S
    Uchiyama, S
    Uchinokura, S
    Shimomura, T
    Miyazawa, K
    Kitamura, N
    Yamada, G
    Kataoka, H
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 2005, 25 (13) : 5687 - 5698
  • [2] Expression of Hepatocyte Growth Factor Activator Inhibitor Type-1 (HAI-1) in Prostate Cancer
    Yasuda, Kenji
    Komiya, Akira
    Watanabe, Akihiko
    Morii, Akihiro
    Oya, Takeshi
    Nagakawa, Osamu
    Fujiuchi, Yasuyoshi
    Fuse, Hideki
    [J]. ANTICANCER RESEARCH, 2013, 33 (02) : 575 - 581
  • [3] Regulation of pericellular proteolysis by hepatocyte growth factor activator inhibitor type 1 (HAI-1) in trophoblast cells
    Kohama, Kazuyo
    Kawaguchi, Makiko
    Fukushima, Tsuyoshi
    Lin, Chen-Yong
    Kataoka, Hiroaki
    [J]. HUMAN CELL, 2012, 25 (04): : 100 - 110
  • [4] Diverse roles of hepatocyte growth factor activator inhibitor type 1 (HAI-1) in the growth of glioblastoma cells in vivo
    Miyata, S
    Uchinokura, S
    Fukushima, T
    Hamasuna, R
    Itoh, H
    Akiyama, Y
    Nakano, S
    Wakisaka, S
    Kataoka, H
    [J]. CANCER LETTERS, 2005, 227 (01) : 83 - 93
  • [5] Regulation of pericellular proteolysis by hepatocyte growth factor activator inhibitor type 1 (HAI-1) in trophoblast cells
    Kazuyo Kohama
    Makiko Kawaguchi
    Tsuyoshi Fukushima
    Chen-Yong Lin
    Hiroaki Kataoka
    [J]. Human Cell, 2012, 25 : 100 - 110
  • [6] Hepatocyte growth factor activator inhibitor type 1 (HAI-1) suppresses tumor growth and metastasis of pancreatic adenocarcinoma cells
    Ye, Jing-Jia
    Kawaguchi, Makiko
    Haruyama, Yukihiro
    Kanemaru, Ai
    Fukushima, Tsuyoshi
    Kataoka, Hiroaki
    [J]. CANCER RESEARCH, 2013, 73
  • [7] Hepatocyte growth factor activator inhibitor-1 (HAI-1) is essential for the integrity of basement membranes in the developing placental labyrinth
    Fan, Bin
    Brennan, Jane
    Grant, Deanna
    Peale, Franklin
    Rangell, Linda
    Kirchhofer, Daniel
    [J]. DEVELOPMENTAL BIOLOGY, 2007, 303 (01) : 222 - 230
  • [8] Prognostic significance of hepatocyte growth factor activator inhibitor type 1 (HAI-1) immunoreactivity in pancreatic ductal adenocarcinoma
    Sakugawa C.
    Haruyama Y.
    Tanaka H.
    Fukushima T.
    Kawaguchi M.
    Kataoka H.
    [J]. BMC Research Notes, 10 (1)
  • [9] Serum hepatocyte growth factor activator inhibitor type I (HAI-1) and type 2 (HAI-2) in prostate cancer
    Nagakawa, O
    Yamagishi, T
    Akashi, T
    Nagaike, K
    Fuse, H
    [J]. PROSTATE, 2006, 66 (05): : 447 - 452
  • [10] In vivo expression of hepatocyte growth factor activator inhibitor type 1 (HAI-1) in preeclamptic term human placenta
    Ishikawa, G
    Mori, M
    Isozaki, T
    Kataoka, H
    Takeshita, T
    Takizawa, T
    [J]. PLACENTA, 2005, 26 (8-9) : A53 - A53